References

[1]  Piketty C, Darragh TM, Da Costa M, Bruneval P, Heard I, Kazatchkine MD, et al High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003; 138: 453–9.
| PubMed |

[2]  Wilkin TJ, Palmer S, Brudney KF, Chiasson MA, Wright TC. Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 2004; 190: 1685–91.
| CrossRef | CAS | PubMed |

[3]  Park IU, Ogilvie JW, Anderson KE, Li ZZ, Darrah L, Madoff R, et al Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia. Gynecol Oncol 2009; 114: 399–403.
| CrossRef | PubMed |

[4]  Kojic EM, Cu-Uvin S, Conley L, Bush T, Onyekwuluje J, Swan DC, et al Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (The SUN Study). Sex Transm Dis 2011; 38: 253–9.
| PubMed |

[5]  Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001; 183: 383–91.
| CrossRef | CAS | PubMed |

[6]  Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994; 83: 205–11.
| CAS | PubMed |

[7]  Nyitray A, Nielson CM, Harris RB, Flores R, Abrahamsen M, Dunne EF, et al Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men. J Infect Dis 2008; 197: 1676–84.
| CrossRef | PubMed |

[8]  Leung WY, Chan PKS, Lau KH, Ho KM. The prevalence of human papilloma virus in the anal region of male Chinese attendees in three public sexually transmitted disease clinics in Hong Kong. Hong Kong J Dermatol Venereol 2011; 19: 6–13.

[9]  Kreimer AR, González P, Katki HA, Porras C, Schiffman M, Rodriguez AC, et al Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol 2011; 12: 862–70.
| CrossRef | CAS | PubMed |

[10]  Hernandez BY, McDuffie K, Zhu X, Wilkens LR, Killeen J, Kessel B, et al Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev 2005; 14: 2550–6.
| CrossRef | PubMed |

[11]  Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Ning L, et al Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort Study. J Infect Dis 2008; 197: 957–66.
| CrossRef | PubMed |

[12]  Hillemanns P, Ellerbrock TV, McPhillips S, Dole P, Alperstein S, Johnson D, et al Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women. AIDS 1996; 10: 1641–7.
| CAS | PubMed |

[13]  Hessol NA, Holly EA, Efird JT, Minkoff H, Schowalter K, Darragh TA, et al Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS 2009; 23: 59–70.
| CrossRef | PubMed |

[14]  Crawford R, Grignon AL, Kitson S, Winder DM, Ball SLR, Vaughan K, et al High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology. BMC Cancer 2011; 11: 473.
| CrossRef | PubMed |

[15]  Valari O, Koliopoulos G, Karakitsos P, Valasoulis G, Founta C, Godevenos D, et al Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications. Gynecol Oncol. 2011; 122: 505–508.
| CrossRef | CAS | PubMed |

[16]  Moscicki AB, Durako SJ, Houser J, Ma Y, Murphy DA, Darragh TM, et al Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents. AIDS 2003; 17: 311–20.
| CrossRef | PubMed |

[17]  Law CL, Thompson CH, Rose BR, Cossart YE. Anal intercourse: a risk factor for anal papillomavirus infection in women? Genitourin Med 1991; 67: 464–8.
| CAS | PubMed |

[18]  Palefsky J. Biology of HPV in HIV infection. Adv Dent Res 2006; 19: 99–105.
| CrossRef | CAS | PubMed |

[19]  Durante AJ, Williams AB, Da Costa M, Darragh TM, Khoshnood K, Palefsky JM. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiol Biomarkers Prev 2003; 12: 638–42.
| PubMed |

[20]  Conley L, Bush T, Darragh TM, Palefsky JM, Unger ER, Patel P, et al Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis 2010; 202: 1567–76.
| CrossRef | CAS | PubMed |

[21]  Tandon R, Baranoski AS, Huang F, de las Morenas A, Vragovic O, Sullivan M, et al Abnormal anal cytology in HIV-infected women. Am J Obstet Gynecol. 2010; 203: 21e1–6.
| CrossRef |

[22]  Gonçalves MA, Randi G, Arslan A, Villa LL, Burattini MN, Franceschi S, et al HPV type infection in different anogenital sites among HIV-positive Brazilian women. Infect Agent Cancer 2008; 3: 5.
| CrossRef | PubMed |

[23]  Shvetsov YB, Hernandez BY, McDuffie K, Wilkens LR, Zhu XM, Ning L, et al Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV Cohort Study. Clin Infect Dis 2009; 48: 536–46.
| CrossRef | PubMed |

[24]  Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, et al Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis 2010; 201: 1331–9.
| CrossRef | PubMed |

[25]  de Pokomandy A, Rouleau D, Ghattas G, Trottier H, Vezina S, Cote P, et al HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis 2011; 52: 1174–81.
| CrossRef | PubMed |

[26]  Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12: 495–503.
| CrossRef | CAS | PubMed |

[27]  Goodman MT, McDuffie K, Hernandez BY, Wilkens LR, Zhu X, Thompson PJ, et al The influence of multiple human papillomavirus types on the risk of genotype-concordant incident infections of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis 2011; 203: 335–40.
| CrossRef | PubMed |

[28]  Hernandez BY, Wilkens LR, Zhu X, Thompson P, McDuffie K, Shvetsov YB, et al Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis 2008; 14: 888–94.
| CrossRef | PubMed |

[29]  Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101: 270–80.
| CrossRef | PubMed |

[30]  Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001; 93: 843–9.
| CrossRef | CAS | PubMed |

[31]  Nyitray AG, Carvalho da Silva RJ, Baggio ML, Lu B, Smith D, Abrahamsen M, et al Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV In Men (HIM) Study. J Infect Dis 2011; 203: 49–57.
| CrossRef | PubMed |

[32]  Burchell AN, Richardson H, Mahmud SM, Trottier H, Tellier PP, Hanley J, et al Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 2006; 163: 534–43.
| CrossRef | PubMed |

[33]  Partridge JM, Hughes JP, Feng Q, Winer RL, Weaver BA, Xi LF, et al Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 2007; 196: 1128–36.
| CrossRef | PubMed |

[34]  Sonnex C, Strauss S, Gray JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Infect 1999; 75: 317–9.
| CrossRef | CAS | PubMed |

[35]  Moscicki AB, Hills NK, Shiboski S, Darragh TM, Jay N, Powell K, et al Risk factors for abnormal anal cytology in young heterosexual women. Cancer Epidemiol Biomarkers Prev 1999; 8: 173–8.
| CAS | PubMed |

[36]  Shvetsov YB, Hernandez BY, Wilkens LR, Thompson PJ, Franke AA, Zhu XM, et al Plasma micronutrients and the acquisition and clearance of anal human papillomavirus infection: the Hawaii HPV Cohort Study. Cancer Res 2010; 70: 9787–97.
| CrossRef | CAS | PubMed |

[37]  Nicolau SM, Camargo CG, Stavale JN, Castelo A, Dores GB, Lorincz A, et al Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection. Urology 2005; 65: 251–5.
| CrossRef | PubMed |

[38]  Van Doornum GJ, Prins M, Juffermans LH, Hooykaas C, van den Hoek JA, Coutinho RA, et al Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourinary Medicine 1994; 70: 240–6.
| CAS | PubMed |

[39]  Nyitray AG, Smith D, Villa L, Lazcano-Ponce E, Abrahamsen M, Papenfuss M, et al Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study. J Infect Dis 2010; 201: 1498–508.
| CrossRef | PubMed |

[40]  Yu CT, Chao SC, Lee HC, Chou CY, Ko WC, Liu HY, et al High prevalence of anal human papillomavirus infection and associated risky behaviors in men infected with human immunodeficiency virus in Taiwan. AIDS Behav 2012; : .
| CrossRef |

[41]  Sirera G, Videla S, Pinol M, Canadas MP, Llatjos M, Ballesteros AL, et al High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS 2006; 20: 1201–4.
| CrossRef | PubMed |

[42]  Nyitray AG, Carvalho da Silva RJ, Baggio ML, Smith D, Abrahamsen M, Papenfuss M, et al Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV In Men Study. J Infect Dis 2011; 204: 1711–22.
| CrossRef | PubMed |

[43]  Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 2010; 46: S20–6.
| CrossRef | PubMed |

[44]  Giuliano AR, Lazcano E, Villa LL, Flores R, Salmeron J, Lee JH, et al Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer 2009; 124: 1251–7.
| CrossRef | CAS | PubMed |

[45]  Franceschi S, Castellsague X, Dal Maso L, Smith JS, Plummer M, Ngelangel C, et al Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002; 86: 705–11.
| CrossRef | CAS | PubMed |

[46]  Vaccarella S, Lazcano-Ponce E, Castro-Garduno JA, Cruz-Valdez A, Diaz V, Schiavon R, et al Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer 2006; 119: 1934–9.
| CrossRef | CAS | PubMed |

[47]  Ferenczy A, Bergeron C, Richart RM. Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections. Obstet Gynecol 1989; 74: 950–4.
| CAS | PubMed |

[48]  Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, et al HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365: 1576–85.
| CrossRef | CAS | PubMed |

[49]  Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, Papenfuss MR, et al Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011; 377: 932–40.
| CrossRef | PubMed |

[50]  Roka S, Rasoul-Rockenschaub S, Roka J, Kirnbauer R, Muhlbacher F, Salat A. Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression. Transpl Int 2004; 17: 366–9.
| CrossRef | PubMed |

[51]  Ogunbiyi OA, Scholefield JH, Raftery AT, Smith JH, Duffy S, Sharp F, et al Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994; 81: 365–7.
| CrossRef | CAS | PubMed |

[52]  Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, et al Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011; 11: 39–44.
| CrossRef | PubMed |